Compliance with Market Abuse Regulation

RNS Number : 5080R
Aberdeen New Dawn Invest Trust PLC
08 November 2021
 

Aberdeen New Dawn Investment Trust plc

Legal Entity Identifier:  5493002K00AHWEME3J36

 

 

8 November 2021

 

Aberdeen New Dawn Investment Trust plc (the "Company") announces that it is satisfied, by virtue of the points listed below, that all inside information which the Directors and the Company may have in the closed period which ends on the date of the announcement of the Half Yearly Report for the six months ended 31 October 2021 has been notified to a Regulated Information Service ("RIS"). The Company is therefore not prohibited from dealing in its own securities during this period.

 

In so stating the Company has regard to:

 

1)  the announcement on 5 November 2021 of the Company's net asset value per share as of the close of business on 31 October 2021,

2)  the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 5 November 2021 and that to be included in the forthcoming announcement of the Half Yearly Financial Report,

3)  the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS,

4)  there being no unquoted investments within the Company's portfolio, and

5)  there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities.

 

If, during the closed period leading up to the announcement of the Half Yearly Financial Report, the Company or its Directors become aware of any inside information, such inside information will be managed in accordance with the UKLA's DTR 2.

 

 

F or further information, please contact:

Gordon Hay Smith

Aberdeen Asset Management PLC

Secretaries

 

Tel. 0131 372 2200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCEAEFSEEFFFFA
UK 100

Latest directors dealings